MRNA short?with states lifting the mask mandates, lifting vaccination requirements for restaurants, CEO of MRNA selling 400M... i think this can be a nice long-short play
MRNA trade ideas
UpdateIMO we need to go down further.. With Earnings coming this month, it can expedite it or change the count. I would try to close my shorts before the earnings.
MRNA - Target Hit! What Next? 🤔Continuation of previous thread where I called the start of this biotechnology bear market and the 1:1 ABC target as been hit.
At the time of making the previous thread the gap down made it clear that the upthrust was a B wave topping out at the typical 0.618 with overnight selling pressure coming in.
And now price has collapsed it is clear to see with long term trendline breaks and the 20 and 50WMA now as resistance that the dominant trend is now to the downside.
For this reason it is most likely that price will now continue to the 1.618 @$94. It may have a small X wave bounce to make a WXY or at may just capitulate in this area for a C wave extension.
And this is why i'm often less concerned about the exact EW count because it is the target fib that is what is important and relevant volatility to make that judgement. Just in the same way that if I invite you round for dinner I won't be overly concerned about the journey you take as long as you do turn up at some point.
I think also in favour of price reaching $94 is that it will intersect the lower trendline and probably go oversold on the weekly RSI.
From there I would imagine there will be another higher degree corrective upthrust before another leg down.
Not advice.
MRNA - Bio Bear Part TroisWhen is the trend your friend until?
This should see $160 and perhaps much lower.
Not advice.
MRNA LONGModerna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). And recently we have seen it fall back to a very cheap price than it was back in 2 August 2021, In its current position we look to buy shares on MRNA as it is currently in a demand level.
strategy for MRNA Thursday 02.03/2022MRNA: we will only buy above ( 178.00 )
MRNA: our bearish entry should only be below (163.00) should not be before this is because the previous day's trend was bearish. if the opening is above (163.00) it is bullish, so we must wait for it to be below
MRNA 1/11/2022Well, as much as some don’t want to admit, Covid just isn’t as serious as it once was back in early 2020. With a 97-99.75 recovery rates, reduction of isolation days from 14 to 5 and no need of covid test after isolation. The dirty Politians have made their money off the vaccines and are cashing out and it reflects on the charts.
Daily Chart Analysis
After breaking out of continuation phase back in March 2020, MRNA went on quite the uptrend that saw price go from $25 to topping out at $497. A price increase of 1888%!
The last leg of the trend was broken end of Sept. 2021. Price then fell past 200ema and pulled back in form of Bear flag to its 50 ema. The bear flag was broken, and price fell below 200ema. This was the end of the uptrend of MRNA. Here we also saw the cross of 50 and 200 EMAs further confirming the bear market. After the breakdown from bear flag, price bounce several times but the EMAs rejected the price and the downtrend continued.
The downtrend is currently strengthening as it is now respecting and rejecting the 20 ema.
Price is currently at support area around 215.50.
Will be looking to short MRNA.
Entry: 223.50
Stoploss: 261.59
Target: trailing 50 ema or 110
MRNANot financial advice.
The essence of investing & trading is the intelligent and patient preying on the greed, fear, impatience, addiction and ignorance of the majority. It's definitionally Darwinian.
Potential Double Bottom On Moderna (NASDAQ: $MRNA) 🧬Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, Metagenomi, Inc., and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd.; Catalent Inc., Laboratorios Farmacéuticos Rovi, S.A., Recipharm, and Lonza Group; Aldevron, LLC; Institute for Life Changing Medicines; and AbCellera Biologics Inc. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
$MRNA flagPotential bottom at the 2.0 st dev of pitchfork, but flagging under the 9ema daily. Like most stocks, consolidated in range for the past week. Calls above 160 or TL resistance. Puts if it fails to break out or below 147.
UpdateMy plan: $123 should come in fast before some relief. I will stay short and short any up move until $123.
MRNAMRNA , 15 min
---------------------Disclaimer ----------------------
I am not a financial /investment advisor. All information I am sharing here is for entertainment purposes only and should not be considered personal investment advice. While the information provided is accurate, it may include errors or inaccuracies. Please, do your diligence when it comes to investing or trading in the market. You are responsible on your choice. Thank you
Moderna long-term short optionModerna is getting hot with Omicron Covid variant.
It almost has no investment attractiveness from current levels, but it has potential for making some sort of reverse pattern (so we will probably see some upward movement in short-term)
You can open potential long-term short positions from fibo levels (red lines)
Dump it!
Before you consider buying MRNA - you should know this .... (There are many people believing that if something is 50% cheaper (half price) then it is a good opportunity. But it can go another 50% lower, then another 50% ... there is no bottom ... there are only decimal places.
While doing my review today ... i looked at the list of insiders transactions. Yes ... MRNA was hugely successful on the way up with 2600% amazing performance. But since the top we are already down quite a lot (ca 60%).
And you also see that insiders (both the President and CEO) keep selling .... in total ca $100m.
Highest price was $350 ... and they keep selling with latest transaction recorded on Jan 13th ....
Ask yourself ... if this was such a great opportunity to buy ... would they be selling???
:)
Elliot Wave Analysis ModernaHello everybody,
As far as I understand, we are in the wave 3 of the wave 5. We surely can see some correctrion up to 275$ in the 4th wave.
It would be nice top hear your ideas and views about this interpretation of Elliott Wave Principle on the example of Moderna stock
BOUNCE/breakout @ $162Has been in a downtrend, meeting a support level
Trading under 50 MA, also from from 50 MA
$MRNA, trading it 1/20For 1/20, intraday trading ideas for options; For red or green market day. #options #daytrading
Break over 181 (entry, long), it can see 188-192 (exit)
Break below 172 (entry, short), it can see 161-165 (exit)
Option Trading 101:
Risk what you can lose (0.5%-5%)
Watch buyers and sellers (their interactions & sentiment, ex. exhaustion of buying or selling, etc.) in strikes that you’re watching & the ticker too; this is how YOU manage YOUR trade.
Consider following and checking out bio and prior posts and recaps (on twitter ), have a great one. NOT FINANCIAL ADVICE.
$MRNA, trading it 1/19For 1/19, intraday trading ideas for options; For red or green market day. #options #daytrading
Break over 199 (entry, long), it can see 206-211 (exit)
Break below 185 (entry, short), it can see 173-178 (exit)
Option Trading 101:
Risk what you can lose (0.5%-5%)
Watch buyers and sellers (their interactions & sentiment, ex. exhaustion of buying or selling, etc.) in strikes that you’re watching & the ticker too; this is how YOU manage YOUR trade.
Consider following and checking out bio and prior posts and recaps (on twitter ), have a great one. NOT FINANCIAL ADVICE.
MRNA Inverse UpdateMRNA going according to plan from my earlier posts. I can't update with charts anymore, for some reason? So I am posting again. Re-iterating targets in the 170-180 range. $230 is the Line in the Sand for bearish continuation. took off a few of my puts today.
Covid could be endemic within weeks with Omicron. MRNA? PFE?While we need another week~ to confirm, many leading scientists are pointing to death rates anywhere from 30% to 90% lower with Omicron. Yes, it's still problematic but there's hope for the first time in a long time. What happens is Omicron becomes the dominant variant and the majority of people have minimal symptoms?
We could see a DRASTIC repricing in some of the vaccine stocks, particularily MRNA. Fair value on MRNA is likely <$100. If we can't reclaim $315, I think we will see $180 and possible $150 within weeks.
I bought some OTM puts for a lotto play :p.
$MRNA, trading it 1/18For 1/18, intraday trading ideas for options; For red or green market day. #options #daytrading
Break over 209 (entry, long), it can see 216-221 (exit)
Break below 197 (entry, short), it can see 185-190 (exit)
Option Trading 101:
Risk what you can lose (0.5%-5%)
Watch buyers and sellers (their interactions & sentiment, ex. exhaustion of buying or selling, etc.) in strikes that you’re watching & the ticker too; this is how YOU manage YOUR trade.
Consider following and checking out bio and prior posts and recaps (on twitter ), have a great one. NOT FINANCIAL ADVICE.
